1. Home
  2. ILMN vs BNTX Comparison

ILMN vs BNTX Comparison

Compare ILMN & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • BNTX
  • Stock Information
  • Founded
  • ILMN 1998
  • BNTX 2008
  • Country
  • ILMN United States
  • BNTX Germany
  • Employees
  • ILMN N/A
  • BNTX N/A
  • Industry
  • ILMN Medical Specialities
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ILMN Health Care
  • BNTX Health Care
  • Exchange
  • ILMN Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • ILMN 23.6B
  • BNTX 23.9B
  • IPO Year
  • ILMN 2000
  • BNTX 2019
  • Fundamental
  • Price
  • ILMN $147.64
  • BNTX $119.34
  • Analyst Decision
  • ILMN Buy
  • BNTX Strong Buy
  • Analyst Count
  • ILMN 19
  • BNTX 15
  • Target Price
  • ILMN $162.67
  • BNTX $143.50
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • BNTX 1.0M
  • Earning Date
  • ILMN 02-06-2025
  • BNTX 11-04-2024
  • Dividend Yield
  • ILMN N/A
  • BNTX N/A
  • EPS Growth
  • ILMN N/A
  • BNTX N/A
  • EPS
  • ILMN N/A
  • BNTX N/A
  • Revenue
  • ILMN $4,390,000,000.00
  • BNTX $3,390,698,192.00
  • Revenue This Year
  • ILMN N/A
  • BNTX N/A
  • Revenue Next Year
  • ILMN $4.28
  • BNTX N/A
  • P/E Ratio
  • ILMN N/A
  • BNTX N/A
  • Revenue Growth
  • ILMN N/A
  • BNTX N/A
  • 52 Week Low
  • ILMN $97.36
  • BNTX $76.53
  • 52 Week High
  • ILMN $156.66
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 56.37
  • BNTX 56.35
  • Support Level
  • ILMN $138.88
  • BNTX $116.73
  • Resistance Level
  • ILMN $151.75
  • BNTX $123.29
  • Average True Range (ATR)
  • ILMN 4.96
  • BNTX 4.89
  • MACD
  • ILMN 0.76
  • BNTX 0.57
  • Stochastic Oscillator
  • ILMN 81.01
  • BNTX 74.90

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: